Published in Proc Natl Acad Sci U S A on June 12, 2003
Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells. Clin Infect Dis (2008) 2.24
Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing. Int J Vasc Med (2012) 1.70
Functional, cellular, and molecular characterization of the angiogenic response to chronic myocardial ischemia in diabetes. Circulation (2007) 1.47
NADPH oxidase-derived overproduction of reactive oxygen species impairs postischemic neovascularization in mice with type 1 diabetes. Am J Pathol (2006) 1.39
Therapeutic angiogenesis in diabetes and hypercholesterolemia: influence of oxidative stress. Antioxid Redox Signal (2009) 1.14
RAGE and soluble RAGE: potential therapeutic targets for cardiovascular diseases. Mol Med (2007) 1.11
Pigment epithelium-derived factor (PEDF) peptide eye drops reduce inflammation, cell death and vascular leakage in diabetic retinopathy in Ins2(Akita) mice. Mol Med (2012) 1.06
Exercise-induced expression of angiogenic growth factors in skeletal muscle and in capillaries of healthy and diabetic mice. Cardiovasc Diabetol (2008) 1.06
Association of increased serum glycated albumin levels with low coronary collateralization in type 2 diabetic patients with stable angina and chronic total occlusion. Cardiovasc Diabetol (2013) 0.94
Angiogenesis impairment in diabetes: role of methylglyoxal-induced receptor for advanced glycation endproducts, autophagy and vascular endothelial growth factor receptor 2. PLoS One (2012) 0.93
Aberrant angiogenesis: The gateway to diabetic complications. Indian J Endocrinol Metab (2012) 0.92
Reversal of hyperglycemia-induced angiogenesis deficit of human endothelial cells by overexpression of glyoxalase 1 in vitro. Ann N Y Acad Sci (2008) 0.92
Obesity induced-insulin resistance causes endothelial dysfunction without reducing the vascular response to hindlimb ischemia. Basic Res Cardiol (2009) 0.91
The possible mechanisms underlying the impairment of HIF-1α pathway signaling in hyperglycemia and the beneficial effects of certain therapies. Int J Med Sci (2013) 0.90
Exercise training and peripheral arterial disease. Compr Physiol (2012) 0.90
Glucose toxic effects on granulation tissue productive cells: the diabetics' impaired healing. Biomed Res Int (2012) 0.87
The AGE-breaker ALT-711 restores high blood flow-dependent remodeling in mesenteric resistance arteries in a rat model of type 2 diabetes. Diabetes (2012) 0.85
Redox balance dynamically regulates vascular growth and remodeling. Semin Cell Dev Biol (2012) 0.85
Impaired collateral recruitment and outward remodeling in experimental diabetes. Diabetes (2008) 0.85
Glycaemic control improves perfusion recovery and VEGFR2 protein expression in diabetic mice following experimental PAD. Cardiovasc Res (2014) 0.81
More sugar, less blood vessels: another piece in the puzzle of increased cardiovascular risk in diabetes. Arterioscler Thromb Vasc Biol (2008) 0.80
Influence of diabetes mellitus on coronary collateral flow: an answer to an old controversy. Heart (2005) 0.78
Imaging the effect of receptor for advanced glycation endproducts on angiogenic response to hindlimb ischemia in diabetes. EJNMMI Res (2011) 0.78
Nanofiber Microenvironment Effectively Restores Angiogenic Potential of Diabetic Endothelial Cells. Adv Wound Care (New Rochelle) (2014) 0.76
Can Chronic Nitric Oxide Inhibition Improve Liver and Renal Dysfunction in Bile Duct Ligated Rats? Adv Pharmacol Sci (2015) 0.75
The receptor for advanced glycation end products impairs collateral formation in both diabetic and non-diabetic mice. Lab Invest (2016) 0.75
Imaging receptor for advanced glycation end product expression in mouse model of hind limb ischemia. EJNMMI Res (2013) 0.75
Ager Deletion Enhances Ischemic Muscle Inflammation, Neoangiogenesis, and Blood Flow Recovery in Diabetic Mice. Arterioscler Thromb Vasc Biol (2017) 0.75
Roles of Nicotinamide Adenine Dinucleotide Phosphate (NADPH) Oxidase in Angiogenesis: Isoform-Specific Effects. Antioxidants (Basel) (2017) 0.75
MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell (1998) 9.70
NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res (2000) 8.62
Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest (1998) 5.95
Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest (1997) 4.31
Molecular mechanisms of blood vessel growth. Cardiovasc Res (2001) 3.94
Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation (1999) 3.16
Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest (1991) 3.00
Pericyte physiology. FASEB J (1993) 2.88
Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol (1999) 2.83
Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation (1999) 2.73
Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J Clin Invest (2000) 2.61
Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med (2003) 2.61
Retracted Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ Res (2002) 2.56
Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc Res (2001) 2.55
Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem Pharmacol (1996) 2.48
Breakers of advanced glycation end products restore large artery properties in experimental diabetes. Proc Natl Acad Sci U S A (1998) 1.92
Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. Circ Res (2001) 1.87
Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest (1998) 1.85
Glycation of collagen: the basis of its central role in the late complications of ageing and diabetes. Int J Biochem Cell Biol (1996) 1.82
Regulation of matrix metalloproteinase activity in ischemic tissue by interleukin-10: role in ischemia-induced angiogenesis. Circ Res (2001) 1.78
Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: A potential predictor for the individual capacity to develop collaterals. Circulation (2000) 1.54
Growth factor-induced angiogenesis in vivo requires specific cleavage of fibrillar type I collagen. Blood (2001) 1.50
Regulation of vascular endothelial growth factor expression by advanced glycation end products. J Biol Chem (2001) 1.45
Advanced glycation end products-driven angiogenesis in vitro. Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor. J Biol Chem (1997) 1.44
Negative consequences of glycation. Metabolism (2000) 1.24
Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J Cell Physiol (1994) 1.21
Aminoguanidine treatment increases elasticity and decreases fluid filtration of large arteries from diabetic rats. J Clin Invest (1993) 1.19
Endothelial nitric oxide synthase lies downstream from angiotensin II-induced angiogenesis in ischemic hindlimb. Hypertension (2002) 1.11
Advanced glycation end products induce angiogenesis in vivo. Microvasc Res (2002) 1.02
Modification of vitronectin by advanced glycation alters functional properties in vitro and in the diabetic retina. Lab Invest (1996) 1.02
Effects of advanced glycation end products on the proliferation and fibronectin production of smooth muscle cells. J Atheroscler Thromb (2000) 1.00
N(carboxymethyl)lysine as a biomarker for microvascular complications in type 2 diabetic patients. Diabetes Metab (2003) 0.98
Glycation-induced matrix stability in the rabbit achilles tendon. Arch Biochem Biophys (2002) 0.98
Toxic action of advanced glycation end products on cultured retinal capillary pericytes and endothelial cells: relevance to diabetic retinopathy. Diabetologia (1997) 0.93
Matrix metalloproteinase activity is enhanced during corneal wound repair in high glucose condition. Curr Eye Res (2000) 0.92
Glucose-induced inhibition of angiogenesis in the rat sponge granuloma is prevented by aminoguanidine. Life Sci (1999) 0.87
Aminoguanidine treatment reduces the increase in collagen stability of rats with experimental diabetes mellitus. Diabetologia (1992) 0.79
Aminoguanidine reduces regional albumin clearance but not urinary albumin excretion in streptozotocin-diabetic rats. Diabetologia (1994) 0.78
Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation (2004) 5.28
Lactadherin promotes VEGF-dependent neovascularization. Nat Med (2005) 2.19
Ex vivo priming of endothelial progenitor cells with SDF-1 before transplantation could increase their proangiogenic potential. Arterioscler Thromb Vasc Biol (2008) 2.16
Vascular endothelial growth factor-B promotes in vivo angiogenesis. Circ Res (2003) 1.92
New guidelines for hemorheological laboratory techniques. Clin Hemorheol Microcirc (2009) 1.89
CD40 ligand+ microparticles from human atherosclerotic plaques stimulate endothelial proliferation and angiogenesis a potential mechanism for intraplaque neovascularization. J Am Coll Cardiol (2008) 1.82
Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma. Eur J Endocrinol (2009) 1.78
Rho-associated protein kinase contributes to early atherosclerotic lesion formation in mice. Circ Res (2003) 1.68
Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity. Arthritis Res Ther (2009) 1.61
Decreased arteriolar density in endothelial nitric oxide synthase knockout mice is due to hypertension, not to the constitutive defect in endothelial nitric oxide synthase enzyme. J Hypertens (2002) 1.54
Improved in vitro biocompatibility of bicarbonate-buffered peritoneal dialysis fluid. Perit Dial Int (2006) 1.44
B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction. Nat Med (2013) 1.43
Changes in glycation and oxidation markers in patients starting peritoneal dialysis: a pilot study. Perit Dial Int (2006) 1.43
Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort. J Rheumatol (2013) 1.42
Post-ischaemic neovascularization and inflammation. Cardiovasc Res (2008) 1.41
NADPH oxidase-derived overproduction of reactive oxygen species impairs postischemic neovascularization in mice with type 1 diabetes. Am J Pathol (2006) 1.39
Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways. Lab Invest (2002) 1.35
Circulating secretory phospholipase A2 activity and risk of incident coronary events in healthy men and women: the EPIC-Norfolk study. Arterioscler Thromb Vasc Biol (2007) 1.34
Oxidation-specific biomarkers, lipoprotein(a), and risk of fatal and nonfatal coronary events. J Am Coll Cardiol (2010) 1.34
Coadministration of endothelial and smooth muscle progenitor cells enhances the efficiency of proangiogenic cell-based therapy. Circ Res (2008) 1.32
Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment. Am J Pathol (2004) 1.31
Inhibition of prolyl hydroxylase domain proteins promotes therapeutic revascularization. Circulation (2009) 1.29
Postischemic revascularization: from cellular and molecular mechanisms to clinical applications. Physiol Rev (2013) 1.28
Evidence of a role for lactadherin in Alzheimer's disease. Am J Pathol (2007) 1.28
Modulation of macrophage activation state protects tissue from necrosis during critical limb ischemia in thrombospondin-1-deficient mice. PLoS One (2008) 1.21
Phospholipase A2 enzymes, high-dose atorvastatin, and prediction of ischemic events after acute coronary syndromes. Circulation (2012) 1.21
Increase in vascular permeability and vasodilation are critical for proangiogenic effects of stem cell therapy. Circulation (2006) 1.20
Ischemia-modified albumin in acute stroke. Cerebrovasc Dis (2006) 1.17
Angiogenesis in the infarcted myocardium. Antioxid Redox Signal (2012) 1.15
Transplantation of bone marrow-derived mononuclear cells in ischemic apolipoprotein E-knockout mice accelerates atherosclerosis without altering plaque composition. Circulation (2003) 1.14
Aldosterone enhances ischemia-induced neovascularization through angiotensin II-dependent pathway. Circulation (2004) 1.12
Endothelial nitric oxide synthase lies downstream from angiotensin II-induced angiogenesis in ischemic hindlimb. Hypertension (2002) 1.11
PSGL-1-mediated activation of EphB4 increases the proangiogenic potential of endothelial progenitor cells. J Clin Invest (2007) 1.11
Retinol-binding protein 4 and prediction of incident coronary events in healthy men and women. J Clin Endocrinol Metab (2008) 1.10
Relationship of IgG and IgM autoantibodies and immune complexes to oxidized LDL with markers of oxidation and inflammation and cardiovascular events: results from the EPIC-Norfolk Study. J Lipid Res (2011) 1.09
Evaluation of the microcirculation in hypertension and cardiovascular disease. Eur Heart J (2007) 1.09
Protein kinase A-dependent phosphorylation of Lutheran/basal cell adhesion molecule glycoprotein regulates cell adhesion to laminin alpha5. J Biol Chem (2005) 1.08
AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression. Kidney Int (2002) 1.05
Regulatory T cells modulate postischemic neovascularization. Circulation (2009) 1.04
RhoA activation and interaction with Caveolin-1 are critical for pressure-induced myogenic tone in rat mesenteric resistance arteries. Cardiovasc Res (2006) 1.04
The chemokine decoy receptor D6 prevents excessive inflammation and adverse ventricular remodeling after myocardial infarction. Arterioscler Thromb Vasc Biol (2012) 1.03
Bone morphogenetic proteins 2 and 4 are selectively expressed by late outgrowth endothelial progenitor cells and promote neoangiogenesis. Arterioscler Thromb Vasc Biol (2008) 1.02
Neuropilin-1 is upregulated in hepatocellular carcinoma and contributes to tumour growth and vascular remodelling. J Hepatol (2011) 1.02
Homeostatic and tissue reparation defaults in mice carrying selective genetic invalidation of CXCL12/proteoglycan interactions. Circulation (2012) 1.01
Thiazolidinediones reduce endothelial expression of receptors for advanced glycation end products. Diabetes (2004) 1.01
Hypertension impairs postnatal vasculogenesis: role of antihypertensive agents. Hypertension (2008) 1.00
Regulation of monocyte subset systemic levels by distinct chemokine receptors controls post-ischaemic neovascularization. Cardiovasc Res (2010) 0.99
Dual effect of angiotensin-converting enzyme inhibition on angiogenesis in type 1 diabetic mice. Arterioscler Thromb Vasc Biol (2004) 0.99
Microparticles from ischemic muscle promotes postnatal vasculogenesis. Circulation (2009) 0.98
Small interfering RNAs induce target-independent inhibition of tumor growth and vasculature remodeling in a mouse model of hepatocellular carcinoma. Am J Pathol (2010) 0.98
The triggering of human peritoneal mesothelial cell apoptosis and oncosis by glucose and glycoxydation products. Nephrol Dial Transplant (2004) 0.98
Flow-dependent dilation mediated by endogenous kinins requires angiotensin AT2 receptors. Circ Res (2004) 0.97
Platelet P2Y12 receptors enhance signalling towards procoagulant activity and thrombin generation. A study with healthy subjects and patients at thrombotic risk. Thromb Haemost (2005) 0.97
Preconditioning by mitochondrial reactive oxygen species improves the proangiogenic potential of adipose-derived cells-based therapy. Arterioscler Thromb Vasc Biol (2009) 0.97
Cross-sectional associations between physical activity and selected coronary heart disease risk factors in young adults. The Cardiovascular Risk in Young Finns Study. Ann Med (2011) 0.96
JAK2V617F activates Lu/BCAM-mediated red cell adhesion in polycythemia vera through an EpoR-independent Rap1/Akt pathway. Blood (2012) 0.95
Role of microvascular rarefaction in the increased arterial pressure in mice lacking for the endothelial nitric oxide synthase gene (eNOS3pt-/- ). J Hypertens (2002) 0.95
Vascular fate of adipose tissue-derived adult stromal cells in the ischemic murine brain: A combined imaging-histological study. Neuroimage (2006) 0.93
Uterine artery structural and functional changes during pregnancy in tissue kallikrein-deficient mice. Arterioscler Thromb Vasc Biol (2003) 0.93
Antiangiogenic effect of angiotensin II type 2 receptor in ischemia-induced angiogenesis in mice hindlimb. Circ Res (2002) 0.92
Interleukin-18/interleukin-18 binding protein signaling modulates ischemia-induced neovascularization in mice hindlimb. Circ Res (2002) 0.92
Involvement of RhoA/Rho kinase pathway in myogenic tone in the rabbit facial vein. Hypertension (2005) 0.91
Bone-marrow-derived very small embryonic-like stem cells in patients with critical leg ischaemia: evidence of vasculogenic potential. Thromb Haemost (2015) 0.91
Molecular basis of angiopathy in diabetes mellitus. Circ Res (2006) 0.91
Erythrocytes and platelet adhesion to endothelium are mediated by specialized molecules. Clin Hemorheol Microcirc (2004) 0.89
Prognostic utility of secretory phospholipase A(2) in patients with stable coronary artery disease. Clin Chem (2011) 0.89
Sympathetic nervous system regulates bone marrow-derived cell egress through endothelial nitric oxide synthase activation: role in postischemic tissue remodeling. Arterioscler Thromb Vasc Biol (2012) 0.88
C/EBP homologous protein-10 (CHOP-10) limits postnatal neovascularization through control of endothelial nitric oxide synthase gene expression. Circulation (2012) 0.88